Ligo Biosciences
PrivateLast Round
Seed
Sep 1, 2024
Total Funding Raised
$500,000
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Ligo Biosciences operates in Healthcare & Life Sciences and is based in San Francisco, California. Its latest recorded funding round was a Seed round in September 2024.
Ligo Biosciences is a biotechnology company that develops generative artificial intelligence models to design novel enzymes for industrial applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clean Manufacturing, Drug Discovery, ML Platforms
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Foundation
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ligo Biosciences Comparables
Compare Ligo Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Biomatter | 87% | |
| Imperagen | 83% | |
| Synthesize Bio | 77% |
For institutional investors. Book with your work email.
Ligo Biosciences Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Ligo Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Wayfinder Ventures | Seed |
| Wayfinder Ventures | Seed |
| Oxonian Ventures | Seed |
| Hawktail Management | Seed |
| Multimodal Ventures | Seed |
| A. Capital Ventures | Seed |
| Y Combinator | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 6, 2026
Co-launched BioBasicsBench, an AI evaluation tool, with OpenAI.
- May 18, 2026
Monthly visitors grew 102% MoM, reaching 1.6K.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- launchesNov 6, 2026
Ligo Biosciences Corporation launches BioBasicsBench, a 100-task benchmark that tests whether AI agents interpret raw laboratory data, identify experimental errors, and recognize when evidence does not support a conclusion, on Nov 6th '26.
For institutional investors. Book with your work email.
Ligo Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Ligo Biosciences's valuation, stock price, and market status.
Is Ligo Biosciences a public or private company?
Ligo Biosciences is a private company.
What is the current stock price of Ligo Biosciences?
Ligo Biosciences is a private company, so its shares have no public market price. Caplight tracks Ligo Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Ligo Biosciences worth (valuation)?
Valuation information for Ligo Biosciences is not publicly available.
Can I buy Ligo Biosciences stock?
Ligo Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Ligo Biosciences's last funding round?
Ligo Biosciences's most recent funding round was Seed on September 1, 2024.
Who are the main investors in Ligo Biosciences?
Key investors in Ligo Biosciences include Wayfinder Ventures, Wayfinder Ventures, Oxonian Ventures, Hawktail Management, Multimodal Ventures.
Will Ligo Biosciences IPO soon?
No public IPO plans have been announced for Ligo Biosciences.
How can I track Ligo Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Ligo Biosciences's shares on secondary markets.